APP and Alzheimer disease: Through IGF1RKO conditional mutant mice and an APP/PS1 AD mouse model, George et al. showed that reduction in neuronal IGF-1R prevents Aβ-induced cognitive deficits and inflammation, which indicates that suppression of IGF-1R signaling can improve AD progression [235].